A CYP1A1 restriction fragment length polymorphism is associated with breast cancer in African-American women.

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

A CYP1A1 restriction fragment length polymorphism is associated with breast cancer in African-American women.

Cancer research - 1 Sept 1995

Taioli E, Trachman J, Chen X, Toniolo P, Garte S J

Abstract excerpt

We examined the role of CYP1A1 polymorphisms as potential molecular markers of breast cancer susceptibility in Caucasian and African-American women. The case-control study involved 51 women with breast cancer and 269 female controls. In African-Americans, the frequency of the homozygous MspI poly...

Topics

Adult
Aged
Black People
Breast Neoplasms
Case-Control Studies
Cytochrome P-450 Enzyme System
Disease Susceptibility
Female
Genotype
Humans
Middle Aged
Polymorphism, Restriction Fragment Length
United States
White People
Black or African American

Source

Open in PubMed

Identifiers

PMID: 7641189

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-7641189-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics